Grifol Antithrombin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grifol Antithrombin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grifol Antithrombin Today - Breaking & Trending Today

Grifols signs global collaboration agreement with Endpoint Health to develop and commercialize Antithrombin III for Sepsis

Published: February 25, 2022

Grifols will be the exclusive supplier of Antithrombin III (AT-III) for treatment of Sepsis, a life-threatening medical emergency Endpoint Health expects to submit its Investigational New Drug (IND) application to the U.S

Source: pressreleasepoint.com

Related Topics:

Comunidad Autonoma De CatalunaGrifols DeuEndpoint HealthDrug AdministrationEndpoint Health IncInvestigational New DrugGrifol AntithrombinInvestigational Device ExemptionJason SpringsChief Executive OfficerArtificial IntelligenceInfectious DiseasesTransfusion MedicineWorld Health OrganizationBlood PlasmaBranches Of BiologyCoagulation SystemIbex 35

Grifols signs global collaboration and licensing agreement with Endpoint Health to develop and commercialize Antithrombin III for Sepsis

Published: February 24, 2022

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com

Related Topics:

Comunidad Autonoma De CatalunaGrifols DeuEndpoint HealthWorld Health OrganizationDrug AdministrationEndpoint Health IncSpanish Stock ExchangeInvestigational New DrugGrifol AntithrombinInvestigational Device ExemptionJason SpringsChief Executive OfficerBio SuppliesMercado ContinuoRoyal Legislative DecreeSecurities Market LawRoyal Decree LawRoyal DecreeHealth OrganizationLicensing AgreementsPr Newswire